Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Wednesday, 4 December 2002
Page: 7119


Senator JACINTA COLLINS (11:54 AM) —I would like to pick up on a couple of Senator Stott Despoja's comments, because we might have an analogous issue with the Prohibition of Human Cloning Bill 2002 that could resolve this issue. On that occasion, when it was argued that this was not the bill to deal with this issue, the government went away and said, `Yes. We acknowledge there is a problem here, and we are prepared to do it through Customs regulation.' The point that Senator Stott Despoja made here is that the therapeutic goods process is probably the more appropriate way to deal with this, and she quite rightly made a number of points about detail that were relevant to how best to ensure that information related to the product would be available.

I do not see any reason why in this matter, especially given Senator Patterson's comments about this not being the place to do it, the government could not give us an assurance that this information could be ensured to stay within the system through the therapeutic goods process. I would have thought that that would be a fairly straightforward way to resolve this issue—a way consistent with Senator Patterson's earlier comments, `If you have such moral standards, let's see you maintain them into the future.' All we are asking for is that that information be maintained into the future so that we can be held to our position. If this is not the appropriate place to do it, let us do it through the therapeutic goods process. I thank Senator Stott Despoja for her advice.